Cargando…
Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice
We have found previously that the tumor cell lines, Renca (a renal cancer) and MC38 (a colon tumor) which had been injected subcutaneously in mice, could be successfully treated with a combination therapy of an oligodeoxynucleotide (CpG1826) (injected intratumorally) and anti-CD137 antibody (injecte...
Autores principales: | Westwood, Jennifer A., Potdevin Hunnam, Titaina C. U., Pegram, Hollie J., Hicks, Rodney J., Darcy, Phillip K., Kershaw, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008493/ https://www.ncbi.nlm.nih.gov/pubmed/24788789 http://dx.doi.org/10.1371/journal.pone.0095847 |
Ejemplares similares
-
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice
por: Westwood, Jennifer A, et al.
Publicado: (2010) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts
por: De Cesare, Michelandrea, et al.
Publicado: (2016) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005) -
Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)